ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRW.GB Craneware Plc

2,281.20
-68.80 (-2.93%)
13:00:59 - Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
Craneware Plc AQSE:CRW.GB Aquis Stock Exchange Ordinary Share GB00B2425G68
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -68.80 -2.93% 2,281.20 2,250.00 2,450.00 2,350.00 2,281.20 2,350.00 917 13:00:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Craneware plc Director/PDMR Shareholding (5226V)

31/01/2017 7:01am

UK Regulatory


Craneware (AQSE:CRW.GB)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Craneware Charts.

TIDMCRW

RNS Number : 5226V

Craneware plc

31 January 2017

Craneware plc

("Craneware" or the "Company")

Director Shareholding

31 January 2017 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, has been informed that Keith Neilson, CEO of the Company, yesterday transferred 49,800 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 1,305 pence per share. Mr. Neilson transferred the shares from his holding to the Neilson Family Foundation, a charity trust set up for the future benefit of medical research and Young People's charities, to which Mr. Neilson is the sole adviser with regards to voting and holding rights.

Following this transaction, Mr. Neilson's beneficial interest in Craneware has reduced to 3,459,718 Ordinary Shares, representing approximately 12.8% of the Company's issued Ordinary Share capital.

For further information, please contact:

 
 Craneware plc    Peel Hunt          Alma 
 +44 (0)131       +44 (0)20 7418     +44 (0)208 004 
  550 3100         8900               4218 
 Keith Neilson,   Dan Webster        Caroline Forde 
  CEO 
 Craig Preston,   Adrian Trimmings    Hilary Buchanan 
  CFO              George Sellar        Robyn McConnachie 
 

About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated value cycle solutions that help US healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware has its headquarters in Edinburgh, Scotland with offices in Atlanta, Boston and Phoenix employing over 200 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHEANFEDFAXEFF

(END) Dow Jones Newswires

January 31, 2017 02:01 ET (07:01 GMT)

1 Year Craneware Chart

1 Year Craneware Chart

1 Month Craneware Chart

1 Month Craneware Chart

Your Recent History

Delayed Upgrade Clock